This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. BI-4142 (Boehringer Ingelheim) is a HER2 exon 20 insertion mutant inhibitor being developed for non-small cell lung cancer (NSCLC).…
molecule
7 months ago ●
5 mins read
together with Jen Huen, Naveed Yasin, Becca Burnham, Arathi Chintireddy, and Adrian Parodi This deep dive into 2021’s novel large…
Article
1 year ago ●
20 mins read
Context. CHF-6366 (Chiesi Farmaceutici S.p.A) is a muscarinic antagonist and β2 agonist (MABA) being developed as an inhaled treatment for…
molecule
7 months ago ●
5 mins read
If you’re here reading about drug discovery for fun, you’re probably a drug hunter. You might be someone on your…
Article
1 year ago ●
9 mins read
Context. “Compound 3f” (Janssen) is an oral Factor XIa (FXIa) inhibitor being developed for thromboembolic diseases. The suitability of FXIa…
molecule
7 months ago ●
4 mins read
with Joachim Rudolph New drugs are discovered by teams, not individuals. "Drug discovery is a complex undertaking, and I enjoy…
Article
1 year ago ●
2 mins read
Load More
